Germany Expects COVID-19 Vaccine In First Quarter Of 2021

According to last week’s report it was said, Germany plans to set up centralised vaccination centres to inoculate priority groups in the first instance, which will be supported by mobile teams

Germany does not expect a coronavirus vaccine to be available before the first quarter of 2021, according to a copy of its national vaccine strategy seen by Reuters on Monday.

The health ministry sets out seven potential vaccines which are expected to complete testing this year or next mentioned in the 15-page strategy paper and is said it could be available in sufficient amounts to begin a nationwide vaccination campaign for priority groups.

These include shots from BioNTech BNTX.O22UAy.DE, AstraZeneca AZN.L and its partner Pfizer PFE.N, Moderna MRNA.O and Novovax NVAX.O, Johnson & Johnson JNJ.N, GlaxoSmithKline GSK.L and CureVac 5CV.DE.

“Assuming that a favourable risk-benefit ratio can be confirmed, first approvals are expected in Q1/2021 at the earliest,” the paper says.

According to last week’s report it was said, Germany plans to set up centralised vaccination centres to inoculate priority groups in the first instance, which will be supported by mobile teams.

The cost of the vaccines will be covered by the German government, while the cost of setting up the vaccination centres will be borne by the states and public and private health insurers where appropriate.

ALSO READ| Common People Might Have To Wait Till 2022 To Get Covid-19 Vaccine, Says AIIMS Director Randeep Guleria

The paper says it expects manufacturers will deliver the shots to distribution centres in multi-dose vials without the syringes and cannulas as well as the required solvent that is needed for vaccination. It has therefore asked the states to procure these accessories.

To get an overview on the effectiveness of the vaccines, Germany will collect non-personal data including information on age, sex, place of residence, vaccination date, vaccine product and vaccination dose administered, the paper says.

Facebook Comments